Results
|
|
81.
|
|
|
|
82.
|
|
|
|
83.
|
|
|
|
84.
|
|
|
|
85.
|
Relationship between topotecan systemic exposure and tumor response in human neuroblastoma xenografts. [electronic resource] by
- Zamboni, W C
- Stewart, C F
- Thompson, J
- Santana, V M
- Cheshire, P J
- Richmond, L B
- Luo, X
- Poquette, C
- Houghton, J A
- Houghton, P J
Producer: 19980416
In:
Journal of the National Cancer Institute vol. 90
Availability: No items available.
|
|
|
86.
|
Studies of the efficacy and pharmacology of irinotecan against human colon tumor xenograft models. [electronic resource] by
- Zamboni, W C
- Stewart, C F
- Cheshire, P J
- Richmond, L B
- Hanna, S K
- Luo, X
- Poquette, C
- McGovren, J P
- Houghton, J A
- Houghton, P J
Producer: 19980528
In:
Clinical cancer research : an official journal of the American Association for Cancer Research vol. 4
Availability: No items available.
|
|
|
87.
|
Translational Pharmacokinetic-Pharmacodynamic Modeling and Simulation: Optimizing 5-Fluorouracil Dosing in Children With Pediatric Ependymoma. [electronic resource] by
- Daryani, V M
- Patel, Y T
- Tagen, M
- Turner, D C
- Carcaboso, A M
- Atkinson, J M
- Gajjar, A
- Gilbertson, R J
- Wright, K D
- Stewart, C F
Producer: 20170811
In:
CPT: pharmacometrics & systems pharmacology vol. 5
Availability: No items available.
|
|
|
88.
|
Pharmacodynamic model of topotecan-induced time course of neutropenia. [electronic resource] by
- Zamboni, W C
- D'Argenio, D Z
- Stewart, C F
- MacVittie, T
- Delauter, B J
- Farese, A M
- Potter, D M
- Kubat, N M
- Tubergen, D
- Egorin, M J
Producer: 20011018
In:
Clinical cancer research : an official journal of the American Association for Cancer Research vol. 7
Availability: No items available.
|
|
|
89.
|
Phase I trial and pharmacokinetic (PK) and pharmacodynamics (PD) study of topotecan using a five-day course in children with refractory solid tumors: a pediatric oncology group study. [electronic resource] by
- Tubergen, D G
- Stewart, C F
- Pratt, C B
- Zamboni, W C
- Winick, N
- Santana, V M
- Dryer, Z A
- Kurtzberg, J
- Bell, B
- Grier, H
- Vietti, T J
Producer: 19961203
In:
Journal of pediatric hematology/oncology vol. 18
Availability: No items available.
|
|
|
90.
|
Probenecid alters topotecan systemic and renal disposition by inhibiting renal tubular secretion. [electronic resource] by
- Zamboni, W C
- Houghton, P J
- Johnson, R K
- Hulstein, J L
- Crom, W R
- Cheshire, P J
- Hanna, S K
- Richmond, L B
- Luo, X
- Stewart, C F
Producer: 19980211
In:
The Journal of pharmacology and experimental therapeutics vol. 284
Availability: No items available.
|
|
|
91.
|
Topotecan-filgrastim combination is an effective regimen for mobilizing peripheral blood stem cells. [electronic resource] by
- Yeoh, E J
- Cunningham, J M
- Yee, G C
- Hunt, D
- Houston, J A
- Richardson, S L
- Stewart, C F
- Houghton, P J
- Bowman, L C
- Gajjar, A J
Producer: 20020801
In:
Bone marrow transplantation vol. 28
Availability: No items available.
|
|
|
92.
|
A phase I/II study of CY and topotecan in patients with high-risk malignancies undergoing autologous hematopoietic cell transplantation: the St Jude long-term follow-up. [electronic resource] by
- Kasow, K A
- Stewart, C F
- Barfield, R C
- Wright, N L
- Li, C
- Srivastava, D K
- Leung, W
- Horwitz, E M
- Bowman, L C
- Handgretinger, R
- Hale, G A
Producer: 20130705
In:
Bone marrow transplantation vol. 47
Availability: No items available.
|
|
|
93.
|
Interpatient variability in bioavailability of the intravenous formulation of topotecan given orally to children with recurrent solid tumors. [electronic resource] by
- Zamboni, W C
- Bowman, L C
- Tan, M
- Santana, V M
- Houghton, P J
- Meyer, W H
- Pratt, C B
- Heideman, R L
- Gajjar, A J
- Pappo, A S
- Stewart, C F
Producer: 19990520
In:
Cancer chemotherapy and pharmacology vol. 43
Availability: No items available.
|
|
|
94.
|
Concordance of DMET plus genotyping results with those of orthogonal genotyping methods. [electronic resource] by
- Fernandez, C A
- Smith, C
- Yang, W
- Lorier, R
- Crews, K R
- Kornegay, N
- Hicks, J K
- Stewart, C F
- Kawedia, J D
- Ramsey, L B
- Liu, C
- Evans, W E
- Relling, M V
- Broeckel, U
Producer: 20121029
In:
Clinical pharmacology and therapeutics vol. 92
Availability: No items available.
|
|
|
95.
|
Assessing vascular effects of adding bevacizumab to neoadjuvant chemotherapy in osteosarcoma using DCE-MRI. [electronic resource] by
- Guo, J
- Glass, J O
- McCarville, M B
- Shulkin, B L
- Daryani, V M
- Stewart, C F
- Wu, J
- Mao, S
- Dwek, J R
- Fayad, L M
- Madewell, J E
- Navid, F
- Daw, N C
- Reddick, W E
Producer: 20160205
In:
British journal of cancer vol. 113
Availability: No items available.
|
|
|
96.
|
Direct translation of a protracted irinotecan schedule from a xenograft model to a phase I trial in children. [electronic resource] by
- Furman, W L
- Stewart, C F
- Poquette, C A
- Pratt, C B
- Santana, V M
- Zamboni, W C
- Bowman, L C
- Ma, M K
- Hoffer, F A
- Meyer, W H
- Pappo, A S
- Walter, A W
- Houghton, P J
Producer: 20000113
In:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 17
Availability: No items available.
|
|
|
97.
|
The role of inherited TPMT and COMT genetic variation in cisplatin-induced ototoxicity in children with cancer. [electronic resource] by
- Yang, J J
- Lim, J Y S
- Huang, J
- Bass, J
- Wu, J
- Wang, C
- Fang, J
- Stewart, E
- Harstead, E H
- E, S
- Robinson, G W
- Evans, W E
- Pappo, A
- Zuo, J
- Relling, M V
- Onar-Thomas, A
- Gajjar, A
- Stewart, C F
Producer: 20130930
In:
Clinical pharmacology and therapeutics vol. 94
Availability: No items available.
|